Home hover Guidelines hover Expert hover Compare hover Faq hover Submit hover About hover Resources hover Syntheses hover Myngc hover Guidelinematrix hover
Home
Browse Guidelines
Expert Commentaries
Guideline Syntheses
Guideline Matrix
Guideline Resources
Compare Guidelines
Frequently Asked Questions
Submit Guidelines
About
myNGC
Search within:  

Sort results by:      



Filter results by:

1-20 of 348   Next >
 
1.  
Colorectal screening for cancer prevention in asymptomatic patients. 2013 Mar 1. NGC:009850
Medical Services Commission, British Columbia - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
3.  
NIH State-of-the-Science Conference Statement on enhancing use and quality of colorectal cancer screening. 2010 Feb. NGC:008272
National Institutes of Health Consensus Development Conference - Independent Expert Panel. View all guidelines by the developer(s)
4.  
American Cancer Society lung cancer screening guidelines. 2013 Mar-Apr. NGC:009686
American Cancer Society - Disease Specific Society. View all guidelines by the developer(s)

View associated Guideline Synthesis
5.  
Screening high-risk populations for lung cancer. 2013 Apr 18. NGC:010035
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
6.  
7.  
Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. 1996 (revised 2012 Jul 17). NGC:009101
U.S. Preventive Services Task Force - Independent Expert Panel. View all guidelines by the developer(s)

View associated Guideline Synthesis
8.  
Cancer screening. 2010 Feb. NGC:009537
Singapore Ministry of Health - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
9.  
Cancer screening. 2004 May (revised 2012 Oct). NGC:009352
University of Michigan Health System - Academic Institution. View all guidelines by the developer(s)
10.  
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. 1980 (revised 2012 May). NGC:009048
American Cancer Society - Disease Specific Society; American Society for Clinical Pathology - Professional Association; American Society for Colposcopy and Cervical Pathology - Medical Specialty Society. View all guidelines by the developer(s)

View associated Guideline Synthesis
11.  
Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. 1996 (revised 2012 Jun 19). NGC:009010
U.S. Preventive Services Task Force - Independent Expert Panel. View all guidelines by the developer(s)

View associated Guideline Synthesis
12.  
ACR Appropriateness Criteria® colorectal cancer screening. 1998 (revised 2013). NGC:010144
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
13.  
ACR Appropriateness Criteria® ovarian cancer screening. 1996 (revised 2012). NGC:009255
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
14.  
Breast cancer screening clinical practice guideline. 2010 Aug. NGC:008538
Kaiser Permanente Care Management Institute - Managed Care Organization. View all guidelines by the developer(s)

View associated Guideline Synthesis
15.  
Screening for oral cancer: U.S. Preventive Services Task Force recommendation statement. 1996 (revised 2014 Jan 7). NGC:010097
U.S. Preventive Services Task Force - Independent Expert Panel. View all guidelines by the developer(s)
16.  
17.  
Recommendations on screening for cervical cancer. 1994 (revised 2013 Jan 8). NGC:009578
Canadian Task Force on Preventive Health Care - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
18.  
Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement. 1996 (revised 2012 Dec 18). NGC:009318
U.S. Preventive Services Task Force - Independent Expert Panel. View all guidelines by the developer(s)
19.  
Recommendations on screening for breast cancer in average-risk women aged 40–74 years. 1994 Jan (revised 2011 Nov). NGC:009058
Canadian Task Force on Preventive Health Care - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)

View associated Guideline Synthesis
20.  
1-20 of 348   Next >